About Haukeland Universitetssjukehus; Klinisk forskningspost
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Haukeland Universitetssjukehus; Klinisk forskningspost
During the past decade, Haukeland Universitetssjukehus; Klinisk forskningspost conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
1995-07-01
Completed
25
MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors
1997-04-01
Completed
5
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
1998-09-01
Completed
704
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
1999-04-01
2015-03-01
Completed
359
Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
1998-07-01
2011-08-01
Completed
360
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Haukeland Universitetssjukehus; Klinisk forskningspost
According to Clinical.Site data, the most researched conditions in "Haukeland Universitetssjukehus; Klinisk forskningspost" are
"Breast Cancer" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Tumors" (1 trials). Many other conditions were trialed in "Haukeland Universitetssjukehus; Klinisk forskningspost" in a lesser frequency.
Clinical Trials Intervention Types at Haukeland Universitetssjukehus; Klinisk forskningspost
Most popular intervention types in "Haukeland Universitetssjukehus; Klinisk forskningspost" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Haukeland Universitetssjukehus; Klinisk forskningspost
The vast majority of trials in "Haukeland Universitetssjukehus; Klinisk forskningspost" are
3 trials for "All" genders.
Clinical Trials Status at Haukeland Universitetssjukehus; Klinisk forskningspost
Currently, there are NaN active trials in "Haukeland Universitetssjukehus; Klinisk forskningspost".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Haukeland Universitetssjukehus; Klinisk forskningspost,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Haukeland Universitetssjukehus; Klinisk forskningspost, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".